Home
Storia in 1 fonti
Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery
Nvidia's venture arm NVentures holds 833,325 shares in Generate:Biomedicines, an AI-driven biotech targeting the $1.8 trillion pharmaceutical market.
Raccontata da
cryptobriefing.com
Timeline cronologica
- ·
Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026
Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life
- ·
Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery
Nvidia's venture arm NVentures holds 833,325 shares in Generate:Biomedicines, an AI-driven biotech targeting the $1.8 trillion pharmaceutical market.